As of 2025-05-18, the Intrinsic Value of Bone Therapeutics SA (BOTHE.BR) is -2.75 EUR. This BOTHE.BR valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.14 EUR, the upside of Bone Therapeutics SA is -2,010.50%.
Based on its market price of 0.14 EUR and our intrinsic valuation, Bone Therapeutics SA (BOTHE.BR) is overvalued by 2,010.50%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -2.75 - -2.75 | -2.75 | -2,010.50% |
| P/E | (0.55) - (1.05) | (0.99) | -787.8% |
| DDM - Stable | (0.15) - (0.34) | (0.25) | -272.4% |
| DDM - Multi | (0.06) - (0.12) | (0.08) | -156.5% |
| Market Cap (mil) | 2.67 |
| Beta | 0.32 |
| Outstanding shares (mil) | 18.55 |
| Enterprise Value (mil) | 23.66 |
| Market risk premium | 6.41% |
| Cost of Equity | 43.59% |
| Cost of Debt | 5.00% |
| WACC | 9.02% |